Magazine Article | March 1, 2019

How Smaller Sponsors Can Compete For Attention At CDMOs

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma
Follow Me On Twitter @Louis_Garguilo

Conventional wisdom holds that startups, virtuals, biotechs, and other smaller pharma companies struggle to compete with their Big Pharma counterparts for capabilities, capacity, pricing, and even attention at CDMOs. But is this always the case? Does it have to be?

Outsourced Pharma brought together a panel of experts at sponsor companies to discuss specifically how small biopharma can compete for attention at CDMOs.